title: [Large doses of cytarabine, etoposide and methotrexate (CEM protocol) in the treatment of lymphoblastic leukemia in adults, resistant to conventional treatment, and of recurrences].
authors.forename: T
authors.initials: T
authors.lastname: Robak
authors.forename: E
authors.initials: E
authors.lastname: Krykowski
authors.forename: W
authors.initials: W
authors.lastname: Matusewicz
authors.forename: T
authors.initials: T
authors.lastname: Olszańska-Skorek
authors.forename: H
authors.initials: H
authors.lastname: Urbańska-Ryś
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged
chemical_list: D003561:Cytarabine; D005047:Etoposide; D008727:Methotrexate
vernacular_title: Duze dawki cytarabiny, etopozydu i metotreksatu (program CEM) w leczeniu ostrej białaczki limfoblastycznej u dorosłych, opornej na konwencjonalne leczenie i w nawrotach.